Does UPADACITINIB Cause Periorbital swelling? 19 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Periorbital swelling have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
19
Reports of Periorbital swelling with UPADACITINIB
0.0%
of all UPADACITINIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Periorbital swelling From UPADACITINIB?
Of the 19 reports, 4 (21.1%) required hospitalization.
Is Periorbital swelling Listed in the Official Label?
Yes, Periorbital swelling is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Periorbital swelling?
DUPILUMAB (885)
AVAPRITINIB (355)
ONABOTULINUMTOXINA (184)
CENEGERMIN-BKBJ (144)
ADAPALENE (142)
OMALIZUMAB (95)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (85)
PEXIDARTINIB (78)
IBUPROFEN (65)
LENALIDOMIDE (58)
Which UPADACITINIB Alternatives Have Lower Periorbital swelling Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL